Clinical Trial Update: Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial of apraglutide in acute graft-versus-host disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Apraglutide (apraglutide)

Snippet

Sponsor: VectivBio AG | Conditions: GVHD | Phase 2 | Status: TERMINATED | Results posted: 2025-10-20